PFAS Biomonitoring 2026

The Wadsworth Center’s Division of Environmental Health Sciences (DEHS) has been selected by the Association of Public Health Laboratories to establish an interlaboratory program for serum testing of per- and polyfluoroalkyl substances (PFAS) by U.S. public health laboratories. PFAS, often called “forever chemicals,” can be measured in serum to assess human exposure. Because serum PFAS testing methods are complex and are used primarily for public health surveillance and human biomonitoring, interlaboratory studies are an important way to support consistent, high-quality testing. Participating laboratories will analyze common samples and return results to the program organizer, who will prepare statistical reports that include consensus values and measures of uncertainty. The samples will support method validation, troubleshooting, and ongoing performance monitoring.


The program will build on the New York State Biomonitoring Proficiency Testing Program for Trace Elements, which already includes serum pools for trace-element testing. These pools will be supplemented with up to 20 PFAS targets at five concentrations spanning the expected analytical range. Wadsworth Center DEHS conducted pilot rounds of serum PFAS testing in 2023 and 2024 with five to 10 volunteer public health laboratories, including the CDC. These pilots demonstrated the feasibility of using the existing serum trace-element pools for a PFAS interlaboratory program. APHL is expected to provide $30,000 annually through its CDC-supported environmental health activities. The program will further strengthen the Wadsworth Center’s leadership in quality assurance for human biomonitoring. 
 

More News